QT
ACHN

Quantbot Technologies’s Achillion Pharmaceuticals ACHN Stock Holding History

Quantbot Technologies’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,400
Closed -$23K – 1732
2019
Q3 		$23K Buy
+6,400
New +$24.7K ﹤0.01% 1099
2016
Q4 		– Sell
-15,310
Closed -$124K – 1469
2016
Q3 		$124K Buy
15,310
+12,855
+524% +$109K 0.01% 681
2016
Q2 		$19K Sell
2,455
-2,306
-48% -$19.8K ﹤0.01% 930
2016
Q1 		$36K Buy
+4,761
New +$34.9K 0.01% 925
2015
Q3 		– Sell
-400
Closed -$3K – 1534
2015
Q2 		$3K Sell
400
-6,100
-94% -$57.7K ﹤0.01% 1048
2015
Q1 		$64K Sell
6,500
-836
-11% -$10.4K 0.02% 721
2014
Q4 		$89K Sell
7,336
-32,295
-81% -$394K 0.03% 692
2014
Q3 		$395K Buy
+39,631
New +$368K 0.05% 469

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quantbot Technologies's ACHN Position: Q4 2019 in Review

Quantbot Technologies sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 6,400 shares — an estimated $23K sold.

Quantbot Technologies first reported a position in ACHN in Q3 2014 and held it in 8 quarters. The position peaked at $395K in Q3 2014. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Quantbot Technologies reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Quantbot Technologies sold 6,400 Achillion Pharmaceuticals shares in Q4 2019, an estimated $23K.
  • Quantbot Technologies first reported a position in Achillion Pharmaceuticals in Q3 2014 and held it in 8 quarters.
  • Quantbot Technologies's Achillion Pharmaceuticals position peaked at $395K in Q3 2014.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Quantbot Technologies's 13F filing for Q4 2019, filed 10 Feb 2020.